Cindy M. Domecus

Conceptus, Inc. develops and markets minimally invasive devices for reproductive medical applications. It sells its products through direct sales force and distribution networks to physicians and hospitals. The company was founded by Kathryn A. Tunstall in 1992 and is headquartered in Mountain View, CA.

Conceptus, Inc. develops and markets minimally invasive devices for reproductive medical applications. It sells its products through direct sales force and distribution networks to physicians and hospitals. The company was founded by Kathryn A. Tunstall in 1992 and is headquartered in Mountain View, CA.

Conceptus, Inc. develops and markets minimally invasive devices for reproductive medical applications. It sells its products through direct sales force and distribution networks to physicians and hospitals. The company was founded by Kathryn A. Tunstall in 1992 and is headquartered in Mountain View, CA.

Conceptus, Inc. develops and markets minimally invasive devices for reproductive medical applications. It sells its products through direct sales force and distribution networks to physicians and hospitals. The company was founded by Kathryn A. Tunstall in 1992 and is headquartered in Mountain View, CA.

Conceptus, Inc. develops and markets minimally invasive devices for reproductive medical applications. It sells its products through direct sales force and distribution networks to physicians and hospitals. The company was founded by Kathryn A. Tunstall in 1992 and is headquartered in Mountain View, CA.

Conceptus, Inc. develops and markets minimally invasive devices for reproductive medical applications. It sells its products through direct sales force and distribution networks to physicians and hospitals. The company was founded by Kathryn A. Tunstall in 1992 and is headquartered in Mountain View, CA.

Conceptus, Inc. develops and markets minimally invasive devices for reproductive medical applications. It sells its products through direct sales force and distribution networks to physicians and hospitals. The company was founded by Kathryn A. Tunstall in 1992 and is headquartered in Mountain View, CA.

Conceptus, Inc. develops and markets minimally invasive devices for reproductive medical applications. It sells its products through direct sales force and distribution networks to physicians and hospitals. The company was founded by Kathryn A. Tunstall in 1992 and is headquartered in Mountain View, CA.

Conceptus, Inc. develops and markets minimally invasive devices for reproductive medical applications. It sells its products through direct sales force and distribution networks to physicians and hospitals. The company was founded by Kathryn A. Tunstall in 1992 and is headquartered in Mountain View, CA.

Conceptus, Inc. develops and markets minimally invasive devices for reproductive medical applications. It sells its products through direct sales force and distribution networks to physicians and hospitals. The company was founded by Kathryn A. Tunstall in 1992 and is headquartered in Mountain View, CA.

Conceptus, Inc. develops and markets minimally invasive devices for reproductive medical applications. It sells its products through direct sales force and distribution networks to physicians and hospitals. The company was founded by Kathryn A. Tunstall in 1992 and is headquartered in Mountain View, CA.

Systemix, Inc. develops cell-based gene therapies for diseases. The company is based in Palo Alto, CA. The company was founded by Irving L. Weissman, Leroy E. Hood. Systemix was acquired by Novartis AG on February 14, 1997 for $75.90 million.

Systemix, Inc. develops cell-based gene therapies for diseases. The company is based in Palo Alto, CA. The company was founded by Irving L. Weissman, Leroy E. Hood. Systemix was acquired by Novartis AG on February 14, 1997 for $75.90 million.

Conceptus, Inc. develops and markets minimally invasive devices for reproductive medical applications. It sells its products through direct sales force and distribution networks to physicians and hospitals. The company was founded by Kathryn A. Tunstall in 1992 and is headquartered in Mountain View, CA.

Systemix, Inc. develops cell-based gene therapies for diseases. The company is based in Palo Alto, CA. The company was founded by Irving L. Weissman, Leroy E. Hood. Systemix was acquired by Novartis AG on February 14, 1997 for $75.90 million.

Systemix, Inc. develops cell-based gene therapies for diseases. The company is based in Palo Alto, CA. The company was founded by Irving L. Weissman, Leroy E. Hood. Systemix was acquired by Novartis AG on February 14, 1997 for $75.90 million.

Conceptus, Inc. develops and markets minimally invasive devices for reproductive medical applications. It sells its products through direct sales force and distribution networks to physicians and hospitals. The company was founded by Kathryn A. Tunstall in 1992 and is headquartered in Mountain View, CA.

Systemix, Inc. develops cell-based gene therapies for diseases. The company is based in Palo Alto, CA. The company was founded by Irving L. Weissman, Leroy E. Hood. Systemix was acquired by Novartis AG on February 14, 1997 for $75.90 million.

Systemix, Inc. develops cell-based gene therapies for diseases. The company is based in Palo Alto, CA. The company was founded by Irving L. Weissman, Leroy E. Hood. Systemix was acquired by Novartis AG on February 14, 1997 for $75.90 million.

Conceptus, Inc. develops and markets minimally invasive devices for reproductive medical applications. It sells its products through direct sales force and distribution networks to physicians and hospitals. The company was founded by Kathryn A. Tunstall in 1992 and is headquartered in Mountain View, CA.

Conceptus, Inc. develops and markets minimally invasive devices for reproductive medical applications. It sells its products through direct sales force and distribution networks to physicians and hospitals. The company was founded by Kathryn A. Tunstall in 1992 and is headquartered in Mountain View, CA.

Systemix, Inc. develops cell-based gene therapies for diseases. The company is based in Palo Alto, CA. The company was founded by Irving L. Weissman, Leroy E. Hood. Systemix was acquired by Novartis AG on February 14, 1997 for $75.90 million.

Systemix, Inc. develops cell-based gene therapies for diseases. The company is based in Palo Alto, CA. The company was founded by Irving L. Weissman, Leroy E. Hood. Systemix was acquired by Novartis AG on February 14, 1997 for $75.90 million.